These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6128320)

  • 1. Induction of ovulation with low-dose estrogen-progestin therapy in amenorrheic patients.
    Ylöstalo P; Huhtaniemi I; Reinilä M
    Int J Fertil; 1982; 27(3):153-9. PubMed ID: 6128320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of ovulation and fertility in amenorrheic women by pulsatile low-dose gonadotropin-releasing hormone.
    Hurley DM; Brian R; Outch K; Stockdale J; Fry A; Hackman C; Clarke I; Burger HG
    N Engl J Med; 1984 Apr; 310(17):1069-74. PubMed ID: 6424012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value and limitations of FSH and LH radioimmunoassay in female sterility and amenorrhea].
    Curchod A; Lemarchand-Béraud T; Achtari H
    Schweiz Med Wochenschr; 1971 Jul; 101(30):1114-21. PubMed ID: 5140627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attempts to induce ovulation in amenorrheic patients using D-Ala-6-LH-RH propylamide.
    Cortés-Prieto J; Arencibia-Rocha J; Aranda A; García-García MD; Coy DH; Schally AV
    Int J Fertil; 1979; 24(2):108-13. PubMed ID: 40903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, controlled trial of estradiol replacement therapy in women with hypergonadotropic amenorrhea.
    Taylor AE; Adams JM; Mulder JE; Martin KA; Sluss PM; Crowley WF
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3615-21. PubMed ID: 8855811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
    BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT; Ohlinger R
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oral estriol on abnormal plasma FSH and LH concentrations in women with unexplained infertility; conception in a patient with elevated FSH and LH.
    Dmowski WP; Rezai P; Auletta FJ; Scommegna A
    Acta Eur Fertil; 1983; 14(1):23-8. PubMed ID: 6426230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The predication of ovarian response in control ovarian hyperstimulation by the ratio of basal FSH and LH level].
    Liang X; Zhuang G; Zhou C
    Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):819-21. PubMed ID: 11798975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of human menopausal gonadotropin therapy at the Boston Hospital for Women (1979-1981).
    Jones KP; Ravnikar VA; Schiff I
    Int J Fertil; 1987; 32(2):131-4. PubMed ID: 2883138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic evaluation of progesterone challenge test in amenorrheic patients (author's transl)].
    Oda T
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Jun; 34(6):751-60. PubMed ID: 6808065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of pathophysiological mechanisms in subjects with amenorrhoea and their value in predicting ovulation induction therapy.
    Shaw RW
    Clin Reprod Fertil; 1982 Sep; 1(3):219-27. PubMed ID: 6821240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose follicle stimulating hormone for ovulation induction in polycystic ovary syndrome.
    Strowitzki T; Seehaus D; Korell M; Hepp H
    J Reprod Med; 1994 Jul; 39(7):499-503. PubMed ID: 7966037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proper selection of patients for intermediate-dose pure follicle stimulating hormone.
    Kim JH; Richards CJ; Seibel MM
    J Reprod Med; 1994 Jan; 39(1):1-5. PubMed ID: 8169907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contraception with pure, synthetic progestogens of the norpregnane group, a new approach for the future?].
    Rozenbaum H
    Contracept Fertil Sex (Paris); 1986 Jun; 14(6):577-81. PubMed ID: 12341096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
    Simon J; Klaiber E; Wiita B; Bowen A; Yang HM
    Menopause; 1999; 6(2):138-46. PubMed ID: 10374221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ovulation induction by the chronic administration of naltrexone in a patient with secondary hypothalamic amenorrhea].
    Sir T; Alba F; Rivera J; Kohen P; Devoto L
    Rev Chil Obstet Ginecol; 1992; 57(1):39-43. PubMed ID: 1342427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The influence of endogenous opioids in hypothalamic amenorrhea. Diagnostic and therapeutic aspects].
    Krause B; Möller S; Ulrich U; Göretzlehner G
    Zentralbl Gynakol; 1989; 111(20):1368-73. PubMed ID: 2555982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Premature ovarian failure.
    Aiman J; Smentek C
    Obstet Gynecol; 1985 Jul; 66(1):9-14. PubMed ID: 3925400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress and therapy of stress amenorrhea.
    Yaginuma T
    Fertil Steril; 1979 Jul; 32(1):36-9. PubMed ID: 378713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.